PHARMACEUTICAL COMPANIES' PRICING POLICY: COMPARATIVE ANALYSIS OF PRACTICES IN UZBEKISTAN AND GLOBAL EXPERIENCE

This article analyzes the economic and institutional foundations of pricing policies in pharmaceutical companies. In this context, the pricing mechanisms applied in the pharmaceutical market of Uzbekistan are comparatively studied alongside the practices of the European Union, the United States, and international organizations. Factors influencing drug pricing, state regulation mechanisms, and cost-plus pricing and value-based pricing models are examined. Furthermore, scientifically grounded conclusions and recommendations for improving pricing policies are presented.